lilly retatrutide Eli Reports Strong Late-Stage Results for Next-Generation Obesity Drug Eli Lilly retatrutide Phase 3

Tirzepatide Efficacy at Low Doses: High Potency, Limited Data Tirzepatide (Mounjaro/Zepbound) hits two receptors (GLP-1 and GIP) instead of one

The net result: reduced appetite (GLP-1), improved insulin action and fat metabolism (GIP), plus increased energy expenditure (glucagon)

On Semaglutide or Tirzepatide, we generally expect 1-3 pounds lost a week

Fitty Tip: Craving something sweet

In a 64-week clinical trial , the Wegovy pill resulted in an average weight loss of 13.6%, and in a 68-week clinical trial, the Wegovy injection produced an average weight loss of 14.9%

Well continue to allow providers to prescribe the way they see fit, said Ahmad